Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
A Pilot Randomized Study on Use of Oral Acetazolamide in Patients With Refractory Dysuria Publisher Pubmed



Hamidi M1 ; Aghamir SMK2 ; Salavati A2 ; Masoomi A1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Urology, Imam Reza Hospital, Aja University of Medical Sciences, Tehran, Iran
  2. 2. Department of Urology, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran

Source: International Urology and Nephrology Published:2017


Abstract

Purpose: Assessment of daily oral acetazolamide in treatment of refractory dysuria. Methods: Forty-one patients were randomly allocated to either be treated with acetazolamide (250 mg twice daily) or to receive placebo. The irritative voiding symptoms and urinary pH were recorded before and after treatment. The quality of life indices including the impact of voiding symptoms on daily and social activities, mood disturbance and sleep disorders were also measured by a questionnaire. Results: Urinary pH was increased in the group taking acetazolamide (P < 0.001). They also reported alleviation of dysuria (P < 0.001), frequency (P = 0.039) and urgency (P = 0.016). However, nocturia was not improved in the study group. No change was observed in the aforementioned parameters in the placebo group. Daily personal life, social activities and the quality of sleep were improved by 52, 38 and 33%, respectively. Conclusion: Oral acetazolamide can reduce the irritative voiding symptoms and improve the quality of life which is concomitant with an increase in urinary pH. © 2017, Springer Science+Business Media Dordrecht.